How to address weight regain after bariatric surgery in an individualized way.

Rev Endocr Metab Disord

Center for the Treatment of Obesity and Diabetes, Hospital Alemao Oswaldo Cruz, São Paulo, Brazil.

Published: October 2023

Bariatric surgery is the most effective obesity treatment. As a chronic and progressive disease, weight loss response to surgery will vary individually. Thus, insufficient weight loss or regain can happen after surgery, but they lack a standard definition. There are different mechanisms underlying weight regain and/or insufficient weight loss, such as genetics, maladaptive eating behaviors, and the inadequate choice of index operations, among others. Patients with weight regain or insufficient weight loss should be submitted to an individualized and comprehensive evaluation by a multidisciplinary team. This may help identify the causes and direct the appropriate treatment individually. Options for patients with insufficient weight loss and/or weight regain following bariatric surgery include repair of postoperative complications, conversion into another operation, endoscopic therapies with inconsistent outcomes, and dietary/behavioral counseling. Revision and conversion surgeries have higher complication rates than primary operations. Although there is no standard pharmacological regimen for that indication, the new agents seem efficient and safe to promote the loss of the regained weight and even be adjunctive to selected patients before they reach the plateau. This review aims to summarize the knowledge of the best approach for patients with weight regain/insufficient weight loss and suggests an algorithm to customize the approach and therapeutic options after bariatric surgery.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11154-023-09806-4DOI Listing

Publication Analysis

Top Keywords

weight loss
24
weight regain
16
bariatric surgery
16
insufficient weight
16
weight
11
regain bariatric
8
patients weight
8
loss
7
surgery
6
regain
5

Similar Publications

In order to investigate the impact of hot air (HA) treatment on the sugars and volatiles in postharvest nectarine fruit, nectarines were treated with HA at 40 °C for 4 h and stored at 1 °C for 35 days. Changes of sugars, free and glycosidically bound volatiles, β-glucosidase (β-Glu) activity, and the gene expression of UGT (UDP-glucosyltransferase) in nectarine fruit were determined. The results showed that compared with CK, HA treatment delayed the firmness decline of 48.

View Article and Find Full Text PDF

Metabolic Dysfunction-Associated Steatotic Liver Disease.

Ann Intern Med

January 2025

Department of Medicine, Division of Gastroenterology and Hepatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts (S.M.J.A., M.L.).

Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease in the United States. It is characterized by steatosis in the liver and is potentially reversible. Risk factors include obesity, type 2 mellitus, and other metabolic disorders.

View Article and Find Full Text PDF

Passive heating in sport: Context specific benefits, detriments, and considerations.

Appl Physiol Nutr Metab

January 2025

Coventry University, Centre for Sport Exercise and Life Sciences, Coventry, Warwickshire, United Kingdom of Great Britain and Northern Ireland;

Exercise and passive heating share some acute physiological responses. These include increases in body temperature, sweat rate, blood flow, heart rate, and redistribution of plasma and blood volume. These responses can vary depending on the heating modality or dose (e.

View Article and Find Full Text PDF

Call to Improve Coding of Cancer-Associated Cachexia.

JCO Oncol Pract

January 2025

Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.

Cachexia is a systemic wasting syndrome prevalent in patients with cancer that significantly affects quality of life, health care costs, and therapeutic outcomes. Despite its clinical importance, cachexia is rarely formally diagnosed. This deficiency presents a challenge for effective patient management and care, health care resource allocation, and the advancement of therapeutic approaches.

View Article and Find Full Text PDF

Vacuolar myopathy with monoclonal gammopathy and stiffness (VAMMGAS).

Eur J Neurol

January 2025

Groupe Hospitalier Pitié-Salpêtrière, Institut de Myologie, AP-HP, Sorbonne Université, Paris, France.

Background: Monoclonal gammopathy (MG) has been reported in association with numerous neurological disorders but the spectrum of MG-associated myopathies remains poorly described.

Objective: To report a newly acquired myopathy associated with MG.

Methods: Three adult patients with the same phenotype from two French referral centers were prospectively analyzed.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!